Luke M. Judge
- Aging top 5%
- Molecular Biology top 5%
- Muscle Physiology and Disorders 7
- Pluripotent Stem Cells Research 6
- CRISPR and Genetic Engineering 5
- Viral Infectious Diseases and Gene Expression in Insects 2
-
- Hereditary Neurological Disorders 2
- Rehabilitation top 5%
-
- 3D Printing in Biomedical Research 4
-
- Adipose Tissue and Metabolism 3
-
- Tissue Engineering and Regenerative Medicine 2
Luke M. Judge
22 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 91
- Aging 67
- Business and International Management 61
- Molecular Biology 1.4k
- Cellular and Molecular Neuroscience 273
- Rehabilitation 89
Countries citing papers authored by Luke M. Judge
This map shows the geographic impact of Luke M. Judge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke M. Judge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke M. Judge more than expected).
Fields of papers citing papers by Luke M. Judge
This network shows the impact of papers produced by Luke M. Judge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke M. Judge. The network helps show where Luke M. Judge may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luke M. Judge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 3 | |
| 6 | 2021 | 16 | |
| 7 | 2021 | 27 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 284 | |
| 10 | 2017 | 63 | |
| 11 | 2016 | 179 | |
| 12 | 2014 | 226 | |
| 13 | 2014 | 190 | |
| 14 | 2011 | 26 | |
| 15 | 2010 | 69 | |
| 16 | 2010 | 75 | |
| 17 | 2009 | 295 | |
| 18 | Gene therapy for Duchenne muscular dystrophy: AAV leads the way. | 2005 | 12 |
| 19 | 2002 | 32 | |
| 20 | 1999 | 2 |
About Luke M. Judge
Luke M. Judge is a scholar working on Aging, Molecular Biology and Rehabilitation, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (7 papers), Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers), 3D Printing in Biomedical Research (4 papers), Adipose Tissue and Metabolism (3 papers), Tissue Engineering and Regenerative Medicine (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Hereditary Neurological Disorders (2 papers). The work is most often cited by research in Aging (67 citations), Business and International Management (61 citations) and Molecular Biology (1.4k citations). Luke M. Judge has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Jeffrey S. Chamberlain, Bruce R. Conklin, Dongsheng Duan, Yi Lai, Dejia Li, Yongping Yue, Mohammad A. Mandegar, Nathaniel Huebsch, Gail D. Thomas and Ronald L. Terjung. Their work appears in journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.